Patents by Inventor Keisuke Nakajou

Keisuke Nakajou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7943570
    Abstract: Glycosylated albumin as a drug carrier for a DDS targeting the liver (particularly kupffer's cell) can be provided by mutating a DNA encoding albumin to encode a mutant albumin containing a partial amino acid sequence permitting glycosylation modification by eukaryotic cell, preferably a consensus sequence of N-linked sugar chain, introducing an expression vector containing the mutant DNA into a host eukaryotic cell, preferably a host cell permitting addition of a high-mannose type sugar chain, culturing the obtained transformant, and recovering a glycosylated albumin protein from the obtained culture.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: May 17, 2011
    Assignee: Nipro Corporation
    Inventors: Keisuke Nakajou, Naohisa Katayama, Toshiya Kai, Masaki Otagiri
  • Publication number: 20090099071
    Abstract: Glycosylated albumin as a drug carrier for a DDS targeting the liver (particularly kupffer's cell) can be provided by mutating a DNA encoding albumin to encode a mutant albumin containing a partial amino acid sequence permitting glycosylation modification by eukaryotic cell, preferably a consensus sequence of N-linked sugar chain, introducing an expression vector containing the mutant DNA into a host eukaryotic cell, preferably a host cell permitting addition of a high-mannose type sugar chain, culturing the obtained transformant, and recovering a glycosylated albumin protein from the obtained culture.
    Type: Application
    Filed: October 16, 2007
    Publication date: April 16, 2009
    Applicant: NIPRO CORPORATION
    Inventors: Keisuke NAKAJOU, Naohisa KATAYAMA, Toshiya KAI, Masaki OTAGIRI
  • Publication number: 20090098607
    Abstract: The present invention provides a production method of a functional recombinant human hemoglobin, which comprises transforming a yeast of the genus Pichia with an expression vector containing a DNA encoding a human hemoglobin ?-chain (Hb?), which is under regulation of a promoter functional in a yeast of the genus Pichia, and an expression vector containing a DNA encoding a human hemoglobin ?-chain (Hb?), which is under regulation of a promoter functional in a yeast of the genus Pichia, culturing the yeast in a medium, and recovering the human hemoglobin from the obtained culture. The present invention also provides an expression vector containing AOX1 promoter, DNA encoding Hb?, terminator functional in a yeast of the genus Pichia, AOX1 promoter, DNA encoding Hb? and terminator functional in the yeast of the genus Pichia in this order from the upstream side in transcriptional direction.
    Type: Application
    Filed: October 16, 2007
    Publication date: April 16, 2009
    Applicant: NIPRO CORPORATION
    Inventors: Keisuke NAKAJOU, Yohei HOASHI, Toshiya KAI, Tadayuki UNO, Masaki OTAGIRI